Follow
Maria Chaparro
Maria Chaparro
Servicio de Aparato Digestivo. Hospital Universitario de La Princesa. Universidad Autónoma de Madrid
Verified email at uam.es - Homepage
Title
Cited by
Cited by
Year
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening
E Quintero, A Castells, L Bujanda, J Cubiella, D Salas, Á Lanas, ...
New England Journal of Medicine 366 (8), 697-706, 2012
11152012
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn …
J Panes, R Bouzas, M Chaparro, V García‐Sánchez, JP Gisbert, ...
Alimentary pharmacology & therapeutics 34 (2), 125-145, 2011
7292011
Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis
DS Kotlyar, JD Lewis, L Beaugerie, A Tierney, CM Brensinger, JP Gisbert, ...
Clinical Gastroenterology and Hepatology 13 (5), 847-858. e4, 2015
4082015
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment
T Raine, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ...
Journal of Crohn's and Colitis 16 (1), 2-17, 2022
3972022
Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed
JP Gisbert, AC Marín, AG McNicholl, M Chaparro
Alimentary pharmacology & therapeutics 41 (7), 613-623, 2015
3262015
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients
M Chaparro, I Ordás, E Cabré, V Garcia-Sanchez, G Bastida, M Peñalva, ...
Inflammatory bowel diseases 19 (7), 1404-1410, 2013
3152013
Systematic review with meta‐analysis: the declining risk of colorectal cancer in ulcerative colitis
C Castaño‐Milla, M Chaparro, JP Gisbert
Alimentary pharmacology & therapeutics 39 (7), 645-659, 2014
3022014
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease
MJ Casanova, M Chaparro, E Domenech, M Barreiro-de Acosta, ...
Official journal of the American College of Gastroenterology| ACG 108 (3 …, 2013
2592013
The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis
JP Gisbert, AC Marin, M Chaparro
Official journal of the American College of Gastroenterology| ACG 111 (5 …, 2016
2022016
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
C Loras, JP Gisbert, M Mínguez, O Merino, L Bujanda, C Saro, ...
Gut 59 (10), 1340-1346, 2010
1992010
Systematic review with meta‐analysis: inflammatory bowel disease in the elderly
JP Gisbert, M Chaparro
Alimentary pharmacology & therapeutics 39 (5), 459-477, 2014
1912014
Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease
MJ Casanova, M Chaparro, B Molina, O Merino, R Batanero, ...
Journal of Crohn's and Colitis 11 (12), 1430-1439, 2017
1832017
Systematic review: antibodies and anti‐TNF‐α levels in inflammatory bowel disease
M Chaparro, I Guerra, P Muñoz‐Linares, JP Gisbert
Alimentary pharmacology & therapeutics 35 (9), 971-986, 2012
1772012
Predictors of primary response to biologic treatment [anti-TNF, vedolizumab, and ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice
JP Gisbert, M Chaparro
Journal of Crohn's and Colitis 14 (5), 694-709, 2020
1762020
Long-term safety ofin uteroexposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study
M Chaparro, A Verreth, T Lobaton, E Gravito-Soares, M Julsgaard, ...
Official journal of the American College of Gastroenterology| ACG 113 (3 …, 2018
1742018
Increasing Incidence of Pediatric Inflammatory Bowel Disease in Spain (1996–2009) The SPIRIT Registry
J Martín-de-Carpi, A Rodríguez, E Ramos, S Jiménez, ...
Inflammatory bowel diseases 19 (1), 73-80, 2013
1742013
Ustekinumab for the treatment of refractory Crohn's disease: the Spanish experience in a large multicentre open-label cohort
S Khorrami, D Ginard, I Marín-Jiménez, M Chaparro, M Sierra, M Aguas, ...
Inflammatory bowel diseases 22 (7), 1662-1669, 2016
1712016
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)
MA Montoro, LJ Brandt, S Santolaria, F Gomollon, BS Puértolas, J Vera, ...
Scandinavian journal of gastroenterology 46 (2), 236-246, 2011
1712011
Microbiota sensing by Mincle-Syk axis in dendritic cells regulates interleukin-17 and-22 production and promotes intestinal barrier integrity
M Martinez-Lopez, S Iborra, R Conde-Garrosa, A Mastrangelo, C Danne, ...
Immunity 50 (2), 446-461. e9, 2019
1682019
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
L Katz, JP Gisbert, B Manoogian, K Lin, C Steenholdt, GJ Mantzaris, ...
Inflammatory bowel diseases 18 (11), 2026-2033, 2012
1532012
The system can't perform the operation now. Try again later.
Articles 1–20